Key result
Pranayama (slow breathing) and yoga may be effective adjuncts to pharmacotherapy for primary and secondary cardiovascular disease prevention by modulating stress and blood pressure.
Why the study?
Does yoga or pranayama improve cardiovascular disease prevention and risk factor modulation in individuals at risk for or with cardiovascular disease?
Does yoga or pranayama improve cardiovascular disease prevention and risk factor modulation in individuals at risk for or with cardiovascular disease?
Yoga and pranayama may offer significant cardiovascular benefits, including blood pressure reduction and stress management, when added to standard pharmacotherapy.
Heart disease continues to be the leading cause of death in both the United States and worldwide. Stress likely plays a prominent role in the development of cardiovascular disease, especially coronary heart disease and hypertension. Yoga is an ancient Indian discipline with the goal of bringing balance and health to the physical, mental, emotional, and spiritual dimensions of an individual. It is a holistic science which is likely one of the best methods for managing stress, reducing anger and hostility in response to daily life events, and preventing overall stress-induced illness. Pranayama is a component of yoga and is a form of breathing exercise, consisting of slow breathing (roughly 6 breaths per minute). It is one of the most practical and effective relaxation techniques. The purpose of this commentary is to further explore the cardiovascular and blood pressure lowering benefits of pranayama. It is plausible that a prescription of yoga, or pranayama in itself, in addition to pharmacotherapy may be even more effective in primary and secondary cardiovascular disease prevention and risk factor modulation than pharmacological intervention alone, given its mental health benefits and thus impact on non-traditional cardiovascular risk factors such as anxiety, depression, hostility, anger, and overall stress, its effects on blood pressure, and its minimal side effects.
No takes yet. Share an insight, caveat, or question.
Ashish Chaddha (2015) conducted a review in Cardiovascular disease. Pranayama (slow breathing) and yoga vs. Pharmacological intervention alone was evaluated. Pranayama (slow breathing) and yoga may be effective adjuncts to pharmacotherapy for primary and secondary cardiovascular disease prevention by modulating stress and blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: